NI
68
-2
DG
8
2
AAL
59
11
SRCL
34
-2
AMP
67
-8
PDCO
50
3
CTSH
56
6
BWA
44
-11
DE
48
2
TROW
48
5
NRG
62
3
GD
52
-5
SLG
70
3
BDX
41
-4
SJM
17
-12
MMM
28
-2
RSG
62
-5
XYL
43
-4
CB
58
-2
MA
64
-3
NI
68
-2
DG
8
2
AAL
59
11
SRCL
34
-2
AMP
67
-8
PDCO
50
3
CTSH
56
6
BWA
44
-11
DE
48
2
TROW
48
5
NRG
62
3
GD
52
-5
SLG
70
3
BDX
41
-4
SJM
17
-12
MMM
28
-2
RSG
62
-5
XYL
43
-4
CB
58
-2
MA
64
-3
Financhill
Back

Monopar Therapeutics 10K Form

Buy
65

MNPR
Monopar Therapeutics

Last Price:
22.04
Seasonality Move:
7.43%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MNPR News And Ratings

See the #1 stock for the next 7 days that we like better than MNPR

MNPR Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-1.68M
Price / Cash Flow: 0
Annual Sales: $1.73
Price / Book: 18.88

Profitability

EPS (TTM): -2.30000
Net Income (TTM): $-7.12M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Monopar Therapeutics Earnings Forecast

Key Monopar Therapeutics Financial Ratios

  • Per Share Earnings over the last 8 years have been positive in 2 years.

Monopar Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MNPR
Website: monopartx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MNPR Technical Analysis vs Fundamental Analysis

Buy
65
Monopar Therapeutics (MNPR) is a Buy

Is Monopar Therapeutics a Buy or a Sell?